Market research
AQS.V Aequus Pharmaceuticals Inc
V CAD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 663K
- P/E ratio
- Not available
- Analyst target
- 2.52
- Dividend yield
- Not available
- Beta
- -0.29
Community
Investor discussion
1 comment
Sign in to join the AQS.V discussion.
5 years, 5 months ago
Aequus Pharmaceuticals Inc is currently in a long term downtrend where the price is trading 21.1% below its 200 day moving average.
From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.2.
Aequus Pharmaceuticals Inc's total revenue rose by 66.9% to $619K since the same quarter in the previous year.
Its net income has increased by 61.9% to $-252K since the same quarter in the previous year.
Finally, its free cash flow grew by 81.1% to $-105K since the same quarter in the previous year.
Based on the above factors, Aequus Pharmaceuticals Inc gets an overall score of 4/5.